Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEMBROLIZUMAB vs PEMETREXED: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PEMBROLIZUMAB vs PEMETREXED: Safety Overview

Metric PEMBROLIZUMAB PEMETREXED
Total FAERS Reports 83,779 23,543
Deaths Reported 15,543 3,876
Death Rate 18.6% 16.5%
Hospitalizations 35,472 10,697
Average Patient Age 64.1 yrs 63.6 yrs
% Female Patients 49.9% 41.0%
FDA Approval Date N/A Aug 18, 2022
Manufacturer Merck Sharp & Dohme LLC BluePoint Laboratories
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Prescription